Archives for July 17, 2018

← 2018

Mylan becomes latest to strike licensing deal with AbbVie for Humira biosimilar

17-Jul-2018

By Ben Hargreaves

AbbVie’s mega-blockbuster Humira is facing biosimilar competition, but another patent licensing agreement, this time with Mylan, sees the company securing exclusivity through to 2023 in the US.

Samsung BioLogics adjudged to have violated accounting standards

17-Jul-2018

By Ben Hargreaves

South Korea’s SFC has alleged that Samsung BioLogics had intentionally omitted information regarding the joint venture agreement with Biogen that created Samsung Bioepis.

Pionyr inks second deal with ProBioGen to push antibody towards clinical trials

17-Jul-2018

By Flora Southey

ProBioGen will use its CHO.RiGHT expression platform to develop and manufacture a second antibody for Pionyr Immunotherapeutics.